Prostaglandin D2 receptor 1 antagonist effective in reducing nicotinic acid-induced vasodilation May 22, 2006
Phase II trial of Manhattan Pharmaceutical's obesity drug candidate cleared in Switzerland May 19, 2006
Advanced Viral Research completes first part of patient enrollment in phase I trial for diabetes May 17, 2006